Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study.

Translated title of the contribution: Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study.

S.C. Gouw, J.G. van der Bom, G. Auerswald, C.E. Ettinghausen, U. Tedgard, H.M. van den Berg

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionRecombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study.
Original languageUndefined/Unknown
Pages (from-to)4693-4697
Number of pages5
JournalBlood
Volume109
Issue number11
Publication statusPublished - 2007

Cite this